Plain-English translation of NCT07652892 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will follow you over time rather than test a new medication. The goal is to understand how fatty liver disease (a condition where fat builds up in the liver) affects your physical strength, thinking, and overall quality of life, and whether these effects differ between men and women.
Fatty liver disease is increasingly common, but doctors don't fully understand how it impacts frailty (physical weakness and difficulty with daily activities), memory, and well-being — especially whether men and women experience it differently. This study aims to fill that gap so future treatments can be more personalized and fair.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic for periodic assessments where doctors will evaluate your physical strength and frailty using standard tests, ask about your memory and thinking, check your hormonal and social well-being, and review your medical history. The study is observational, so there is no new medication to take — researchers are simply gathering information to understand how fatty liver disease affects different people over time.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment target
~140 participants
Started
May 2026
Primary completion
February 2027
Age range
20 Years – 80 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eva Román, Digestive Pathology Nurse
Institut de Recerca IR Sant Pau
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.